Top Doctor
The Top Doctor award is a peer-nominated award for providers who give exceptional care.

Andrew Coveler, MD

Director, Pancreatic Cancer Specialty Clinic
Seattle Cancer Care Alliance
Associate Professor, Medical Oncology
University of Washington School of Medicine
UW Medicine
Associate Professor, Clinical Research Division
Fred Hutchinson Cancer Research Center
Clinical expertise
Gastrointestinal oncology
“I want your treatment to be integrated into your life, not to consume it.”
— Dr. Coveler
Why did you choose to join SCCA?

I wanted to work at an institution that provides patient-centered care and plentiful opportunities for people to take part in clinical trials with new and novel treatments. SCCA has been at the forefront of using the immune system to fight cancer. Though there has been limited success so far bringing immune-based therapies to GI cancers, I am hopeful it will happen. In addition, I enjoy working with the next generation of physicians, and I am able to do that by being a part of SCCA and its partner organizations.

What’s your approach to working with patients?

My goal is to partner with you and your family so that you can take an active role in your care. I am an advocate for your choices so that you can confront the disease on your own terms. I strive to guide you through what’s unknown, sharing information about your disease, prognosis and treatment options. It is an honor to care for people with challenging diagnoses.

Provider background

Specialties and clinical expertise: Medical Oncology

Pancreatic cancer

As the director of the Pancreatic Cancer Specialty Clinic, I review almost all the records of patients coming to SCCA with pancreas cancer. You are likely to see one of my colleagues, but we often start the evaluation before you walk in the door so that your first visit is useful to you.

Esophageal, stomach, small bowel, colon, anal and liver cancers (including neuroendocrine tumors)

I am a medical oncologist who treats people with cancers of the gastrointestinal (GI) system, which includes many organs, such as the stomach and liver. My research spans several GI cancers. As a member of the Phase I Program, I collaborate with colleagues to bring new and novel therapies to SCCA and those who come here for care.

Diseases treated

Education, experience and certifications
Undergraduate Degree
Northwestern University
Medical Degree
Northwestern University Medical School
University of Washington, General Internal Medicine
University of Washington, Tumor Vaccine Group; University of Washington, Hematology-Oncology
Board Certification
Medical Oncology, 2010, American Board of Internal Medicine
Internship, Baylor College of Medicine
Seattle Met's 2016 Top Doctors award

Dr. Coveler was nominated by his peers for this award, because of his exceptional care.

Stories and testimonials

For some patients with pancreatic cancer, a newly introduced procedure at SCCA provides hope

When John Nowoj was diagnosed with locally advanced pancreatic cancer in August 2019, he was told the cancer was inoperable. Nowoj, 57, began pursuing his only treatment option: chemotherapy to be followed by radiation, which could shrink but not eradicate the tumor. Then an unexpected development completely changed the outlook.

“Dr. Coveler is a natural leader who is able to bring a diverse group of people together for the common good of each patient — and he does so with directness, levity and compassion. ”
— Jonathan Sham, MD


Clinical trials

We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.

Study ID:
Pembrolizumab in Refractory Metastatic Anal Cancer
Complete title
A Multicenter Phase 2 Clinical Trial of Pembrolizumab in Metastatic Anal Cancer
Study ID:
Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)
Complete title
PANOVA-3: Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 150kHz) concomitant with gemcitabine and nab-paclitaxel for front-line treatment of locally-advanced pancreatic adenocarcinoma
Study ID:
Safety Study of SEA-CD40 in Cancer Patients
Complete title
A Phase 1, Open-Label, Dose-Escalation Study of SEA-CD40 in Adult Patients with Advanced Malignancies


Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.


SCCA providers are often asked to give their medical expertise for press and news publications. Read articles by or about this SCCA provider.

Cierra sisters host annual world cancer day event dedicated to embracing knowledge

SCCA’s Julie Gralow, MD, and Andrew Coveler, MD, recently participated in Cierra Sisters annual World Cancer Day event.

Your care team

At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Annie Alidina, ARNP
Advanced Registered Nurse Practitioner
Advanced Practice Provider
Phase 1 clinical trials
Leslie A. Swanson, ARNP
Advanced Registered Nurse Practitioner
Advanced Practice Provider
Gastrointestinal diseases
Registered nurse (RN)
Your nurse manages your care alongside your physician and assists with care procedures and treatments.
Team coordinator (TC)
Your team coordinator works closely with you and your physician and serves as your scheduler.


SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.

For providers